| Variable | African ancestry n = 1303 | Other ethnicity n = 7373 | Unknown ethnicity n = 1096 | Total n = 9772 |
|---|---|---|---|---|
| Age, yr, median | 33 | 35 | 36 | 35 |
| Sex, female | 0.55 | 0.12 | 0.19 | 0.19 |
| Likely mode of transmission | ||||
| Heterosexual | 0.68 | 0.14 | 0.13 | 0.21 |
| Men who have sex with men | 0.15 | 0.68 | 0.35 | 0.57 |
| Injection drug use | 0.01 | 0.11 | 0.17 | 0.11 |
| Other or unknown | 0.15 | 0.07 | 0.36 | 0.11 |
| Hepatitis C co-infection | 0.03 (201) | 0.18 (810) | 0.19 (353) | 0.16 (1364) |
| Hepatitis B co-infection | 0.06 (192) | 0.04 (1078) | 0.02 (549) | 0.04 (1819) |
| Calendar year of cohort enrolment | ||||
| Before 2000 | 0.09 | 0.21 | 0.22 | 0.20 |
| 2000−2004 | 0.40 | 0.38 | 0.43 | 0.39 |
| 2005–2009 | 0.51 | 0.41 | 0.35 | 0.42 |
| No. of CD4 cell count measurements, median | 5 | 6 | 5 | 6 |
| CD4 cell count, cells/μL, median | 400 | 470 | 470 | 460 |
| CD4%, median | 23 (225) | 26 (932) | 26 (51) | 26 (1208) |
| CD8 cell count, cells/μL, median | 880 (275) | 940 (1163) | 900 (53) | 920 (1491) |
| HIV RNA, log copies/mL, median | 4.0 (10) | 4.4 (56) | 4.5 (3) | 4.3 (69) |
| Follow-up time, yr, median | 1.42 | 1.76 | 1.56 | 1.69 |